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Summary
To understand the process of cardiac aging, it is of crucial impor-
tance to gain insight into the age-related changes in gene expres-
sion in the senescent failing heart. Age-related cardiac remodeling
is known to be accompanied by changes in extracellular matrix
(ECM) gene and protein levels. Small noncoding microRNAs regu-
late gene expression in cardiac development and disease and have
been implicated in the aging process and in the regulation of ECM
proteins. However, their role in age-related cardiac remodeling
and heart failure is unknown. In this study, we investigated the
aging-associated microRNA cluster 17–92, which targets the ECM
proteins connective tissue growth factor (CTGF) and thrombo-
spondin-1 (TSP-1). We employed aged mice with a failure-resistant
(C57Bl6) and failure-prone (C57Bl6 · 129Sv) genetic background
and extrapolated our findings to human age-associated heart fail-
ure. In aging-associated heart failure, we linked an aging-induced
increase in the ECM proteins CTGF and TSP-1 to a decreased
expression of their targeting microRNAs 18a, 19a, and 19b, all
members of the miR-17–92 cluster. Failure-resistant mice showed
an opposite expression pattern for both the ECM proteins and the
microRNAs. We showed that these expression changes are specific
for cardiomyocytes and are absent in cardiac fibroblasts. In cardio-
myocytes, modulation of miR-18 ⁄ 19 changes the levels of ECM
proteins CTGF and TSP-1 and collagens type 1 and 3. Together, our
data support a role for cardiomyocyte-derived miR-18 ⁄ 19 during
cardiac aging, in the fine-tuning of cardiac ECM protein levels. Dur-
ing aging, decreased miR-18 ⁄ 19 and increased CTGF and TSP-1 lev-
els identify the failure-prone heart.
Key words: cardiac aging; connective tissue growth factor;
matricellular proteins; microRNA; miR-18; miR-19; thrombo-
spondin-1.
Introduction
Aging is considered a multifactorial process that is controlled by genetic
and environmental factors and ultimately leads to deterioration of body
and organ functions. Heart failure (HF) is a typical age-associated disease
and is characterized by unique physiological and morphological changes
in aged myocardium [reviewed in (Lakatta & Sollott, 2002)]. Although the
rate and mechanism through which an animal or tissue ages differ among
species, the constant remodeling and accumulation of the extracellular
matrix (ECM) are recognized as a key feature of cardiac aging in humans,
mice, and rats and contributes to the structural changes that lead to HF
with advancing age (Capasso et al., 1990; Barasch et al., 2009; Boyle
et al., 2011). In particular, the expression of the ECM proteins SPARC
(Bradshaw et al., 2010), fibronectin (Burgess et al., 2001), thrombospon-
din-2 (TSP-2) (Swinnen et al., 2009), and connective tissue growth factor
(CTGF) (Wang et al., 2010) increases with aging. Both TSP-2 knockout
mice and cardiomyocyte-specific CTGF transgenic animals develop spon-
taneous age-related cardiomyopathy (Panek et al., 2009; Swinnen et al.,
2009), confirming a role of ECM proteins in age-related cardiac remodel-
ing. However, the underlying mechanisms that drive the age-related gene
expression of ECMmolecules remain elusive.
The identification of small noncoding microRNAs (miRNAs) opened
new doors for investigating the regulation of gene expression by adding
another layer of control at the post-transcriptional level. MiRNAs are
approximately 22 nucleotides long RNA molecules that can target mRNAs
for translational repression or degradation by complementary binding to
specific sequences in the protein-coding gene transcript. The first implica-
tion of miRNAs in aging was provided by a study that showed that lin-4
and its target protein lin-14 determine longevity in C. elegans by affect-
ing the insulin-like signaling pathway (Boehm & Slack, 2005). Now, miR-
NAs have emerged as important mediators of diverse age-associated
pathologies, ranging from cancer and diabetes to neurodegenerative dis-
orders (Grillari & Grillari-Voglauer, 2010), and increasing evidence dem-
onstrates altered miRNA expression profiles in aging muscle, brain, lung,
and liver [reviewed in (Chen et al., 2010)]. In addition, miRNAs are regu-
lated during cellular senescence, and complete loss of miRNA function
caused premature senescence in embryonic fibroblasts (Mudhasani et al.,
2008), putting miRNAs in the forefront of cellular senescence in different
organs and cell types (Chen et al., 2010; Grillari and Grillari-Voglauer,
2010). Their role in the heart was first suggested by expression profiling
studies showing changes in the expression of specific miRNAs in failing
human hearts (van Rooij et al., 2006; Thum et al., 2007). Further animal
models proved the involvement of specific miRNAs in cardiac develop-
ment, function, and under pathological conditions (van Rooij et al., 2007;
Zhao et al., 2007; da Costa Martins et al., 2010). Nevertheless, despite
their proven importance in aging, cardiac disease, and development, a
role for miRNAs during cardiac aging and age-related HF remains to be
elucidated.
This study investigated the role of the miR-17–92 cluster in the aged
heart, in view of its central role in regulation of matrix genes and in cellu-
lar aging (Dews et al., 2006; Suarez et al., 2008; Shan et al., 2009). This
cluster encodes six miRNAs (miR-17, miR-18a, miR-19a, miR-19b, miR-
20a, and miR-92a-1) that are located within an 800-base pair region of
human chromosome 13. Originally, the miR-17–92 cluster was linked to
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tumor genesis, and transcription of the cluster was found to be directly
activated by the proto-oncogene c-Myc (He et al., 2005) [reviewed in(van
Haaften & Agami, 2010)]. The pro-oncogenic activity of miR-17–92 par-
tially involves the regulation of the ECM proteins CTGF and thrombo-
spondin-1 (TSP-1) by the cluster members miR-18 and miR-19, through
sequence-specific targeting within the 3¢-untranslated region (3¢-UTR) of
these gene transcripts (Supporting information Fig. S1) (Dews et al.,
2006). Interestingly, cardiogenesis was severely hampered in mice defi-
cient for miR-17–92, suggesting an important role for this cluster in car-
diac development (Ventura et al., 2008). This, together with miR-18 and
miR-19 targeting CTGF and TSP-1 and the fact that ECM proteins are cru-
cial for healthy cardiac aging, has led us to hypothesize that these miRNAs
play a role in age-related cardiac remodeling. Therefore, we investigated
whether age-related changes in miR-18a, miR-19a, and miR-19b expres-
sion regulate CTGF, TSP-1, and collagen levels in rodent models of aging-
associated heart failure and in the human failing heart.
Results
HF-prone mice develop cardiac dilation and dysfunction at
old age
As a model for age-related HF in rodents, we examined age-associated
changes in cardiac function in two genetically different mouse strains, i.e.
C57Bl6 (HF resistant) and C57Bl6 · 129Sv (HF prone). Both strains devel-
oped normally, and echocardiographic analysis showed no differences in
cardiac function at 12 and 52 weeks of age. However, fractional shorten-
ing was significantly compromised in 104-week-old HF-prone mice com-
pared to age-matched HF-resistant hearts (Table 1). Indices of left
ventricular wall thickness, LVPW and IVS, indicated progressive thinning
of the LV wall with aging in HF-prone mice, followed by ventricular dila-
tion at old age (Table 1). HF-resistant mice on the other hand had no ven-
tricular dilation and showed a tendency to increased wall thickness with
aging, resulting in a preserved cardiac function at old age (Table 1). Age-
associated cardiac dysfunction in HF-prone mice was further shown by
significantly higher heart, kidney, and lung weights at old age (Table 1).
Thus, poor cardiac aging in HF-prone mice was characterized by a dilated
cardiomyopathy-like phenotype as is seen in human HF.
HF-prone hearts have more interstitial fibrosis and increased
levels of CTGF and TSP-1
Dilated cardiomyopathy is characterized by increased deposition of inter-
stitial collagen, stiffening the heart, and compromising its contractility
(Kemi et al., 2000; Burgess et al., 2001). Histological examination of car-
diac sections showed significant interstitial fibrosis in HF-prone mice as
compared to 52-week littermates and to 104-week-old HF-resistant
hearts (Fig. 1A, B). On the other hand, the mild increase in collagen in
aged HF-resistant mice was not significant (Fig. 1A, B), while accumula-
tion of interstitial collagen was similar in 12- and 52-week-old HF-resis-
tant and HF-prone mice. As expected, perivascular fibrosis increased with
aging, but was not different between HF-prone and HF-resistant hearts
(Fig. 1A, B).
The ECM proteins CTGF and TSP-1 are recognized as powerful regula-
tors of ECM remodeling and are mediators of tissue fibrosis in humans,
mice, and rats (Belmadani et al., 2007; Shi-Wen et al., 2008). We found
significantly increased cardiac transcript and protein levels of CTGF and
TSP-1 in 104-week-old HF-prone mice (Fig. 2A, B; Supporting informa-
tion Fig. S2). Vice versa, the hearts of aged HF-resistant mice had no
induction of CTGF and TSP-1 transcript or protein levels (Fig. 2A, B).
Therefore, increased interstitial fibrosis and CTGF and TSP-1 expression
characterize the HF-prone aged heart.
Opposite cardiac miR-17–92 cluster expression profiles in
HF-resistant and HF-prone aging
CTGF and TSP-1 have been identified as target genes of the miR-17–92
cluster (Dews et al., 2006), more specifically of the cluster members
miR-18a and miR-19a ⁄ b (Suarez et al., 2008; Ohgawara et al., 2009).
We found opposite expression profiles of the miR-17–92 cluster in
Table 1 Echocardiographic and morphometric analysis of male mice at different ages
HF resistant HF prone
12 weeks n = 8 52 weeks n = 8 104 weeks n = 9 12 weeks n = 9 52 weeks n = 7 104 weeks n = 8
FS (%) 28 ± 1.5 29 ± 1.6 29 ± 1.7 28 ± 2.0 29 ± 3.5 20 ± 2.2*†
LVIDd (mm) 4.0 ± 0.1 4.2 ± 0.1 4.2 ± 0.1 3.8 ± 0.2 3.7 ± 0.2 4.6 ± 0.2*†
LVIDs (mm) 2.9 ± 0.1 3.0 ± 0.1 3.0 ± 0.1 2.7 ± 0.1 2.7 ± 0.2 3.7 ± 0.3*†
LVPWd (mm) 0.75 ± 0.03 0.84 ± 0.03* 0.90 ± 0.03* 0.99 ± 0.11 0.91 ± 0.05 0.88 ± 0.06
LVPWs (mm) 1.16 ± 0.06 1.18 ± 0.06 1.27 ± 0.04 1.40 ± 0.08 1.22 ± 0.04 1.02 ± 0.07*†
IVSd (mm) 0.72 ± 0.01 0.81 ± 0.03* 0.81 ± 0.04* 0.96 ± 0.15 0.91 ± 0.05 0.83 ± 0.03
IVSs (mm) 1.03 ± 0.01 1.22 ± 0.04* 1.18 ± 0.07 1.41 ± 0.18 1.37 ± 0.09 1.06 ± 0.06†
Heart rate (bpm) 482 ± 14 473 ± 11 493 ± 8 506 ± 15 521 ± 9 502 ± 25
Body weight (g) 25.0 ± 0.3 30.8 ± 0.5* 33.2 ± 0.8*† 23.5 ± 1.1 29.8 ± 0.7* 29.8 ± 0.7*
HW ⁄ BW ratio (mg g)1) 4.8 ± 0.1 4.8 ± 0.2 4.4 ± 0.1* 5.4 ± 0.2 5.5 ± 0.1 6.0 ± 0.3
LuW ⁄ BW ratio (mg g)1) 5.7 ± 0.3 5.7 ± 0.2 6.2 ± 0.2 5.9 ± 0.3 5.9 ± 0.3 7.5 ± 1.0
LiW ⁄ BW ratio (mg g)1) 48.0 ± 0.7 47.7 ± 1.1 48.1 ± 0.9 47.0 ± 2.8 46.6 ± 1.6 53.7 ± 3.8
KiW ⁄ BW ratio(mg g)1) 8.0 ± 0.2 8.7 ± 0.3 8.7 ± 0.2 8.8 ± 0.4 11.9 ± 0.3* 11.3 ± 0.4*
FS, fractional shortening; HF, Heart failure; LVIDd and LVIDs, left ventricular internal diameter in diastole and systole; LVPWd and LVPWs, left ventricular posterior wall
thickness in diastole and systole; IVSd and IVSs, intraventricular septum thickness in diastole and systole; HW, heart weight; BW, body weight; LuW, lung weight; LiW,
liver weight; KiW, kidney weight.
*P £ 0.05 vs 12 weeks of age with the same genotype.
†P £ 0.05 vs 52 weeks of age with the same genotype.
P £ 0.05 vs HF-resistant mice with the same age.
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HF-prone aging compared to aging with preserved cardiac function. At
104 weeks of age, HF-prone mice had significantly reduced expression
levels of miR-17, miR-18a, miR-19a, miR-19b, miR-20a, and miR-92a-1
as compared to 12-week littermates (Fig. 2C and Supporting informa-
tion Table S1), coinciding with the observed increased presence of their
targets TSP-1 and CTGF. Aging of HF-resistant mice, on the other hand,
was accompanied by significantly enhanced expression of these
miRNAs, except for miR-17 and miR-20a (Supporting information
Table S1).
The miR-18 ⁄ 19 – CTGF ⁄ TSP-1 axis is regulated in human age-
associated heart failure
The three miR-17–92 cluster members miR-18a, miR-19a, and miR-19b
specifically target the ECM proteins CTGF and TSP-1. To investigate the
role of these genes in human HF, we studied their expression profiles in
cardiac biopsies of idiopathic cardiomyopathy (ICM) patients at old age
with a moderately decreased or preserved systolic function (ejection frac-
tion (EF) between 40 and 55%) (Paulus et al., 2007) and severely
12 weeks old 52 weeks old 104 weeks old
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Fig. 1 Enhanced left ventricular interstitial fibrosis in old heart
failure (HF) prone mice. (A) Histological analysis of the hearts
of HF-resistant and HF-prone mice by Sirius Red staining.
Photographs show representative areas of interstitial fibrosis
(upper panel) and collagen deposition in the perivascular area
(lower panel). Scale bars represent 100 lm. (B) Quantitative
analysis of the interstitial and perivascular collagen content in
HF-resistant (12 weeks, n = 8; 52 weeks, n = 8; and
104 weeks, n = 9) and HF-prone mice (12 weeks, n = 6;
52 weeks, n = 11; and 104 weeks, n = 9) revealed increased
interstitial fibrosis in the left ventricles of 104-week-old
HF-prone mice. Perivascular fibrosis was significantly increased
in 104-week-old hearts, but was not different between
HF-resistant and HF-prone mice. Data are presented as
mean ± SEM. *P £ 0.05 vs 52-week-old HF-prone mice;
†P £ 0.05 vs 104-week-old HF-resistant mice.
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impaired cardiac function (EF < 30%) and compared them to young ICM
subjects. In line with reduced expression levels in failing hearts of old
mice, decreased miR-18a, miR-19a, and miR-19b expression was associ-
ated with severe heart failure at old age (Fig. 3A), while miRNA expres-
sion in old patients with a preserved function was not different from
young ICM patients (Fig. 3A). Additionally, CTGF and TSP-1 transcript lev-
els were significantly induced in old failing ICM hearts, which further cor-
roborates our findings in old HF-prone mice (Fig. 3B). Together, these
data suggest that regulation of CTGF and TSP-1 is the result of the shared
expression of miR-18a, miR-19a, and miR19b, enabling modest changes
in miRNA expression to control transcriptional repression.
The miR-18 ⁄ 19 – CTGF ⁄ TSP-1 axis is regulated in aged
cardiomyocytes in vitro
To gain further insight into the role of the miR-17–92 cluster in aging
of cardiomyocytes, neonatal rat cardiomyocytes (NRCMs) were aged
in vitro, and miRNA levels were determined.
Aging of cardiomyocytes in vitro was validated by comparing the lipo-
fuscin content in 4- and 21-day-old NRCMs to the intracellular accumula-
tion of lipofuscin in the hearts of 12- and 104-week-old C57Bl6 mice.
Lipofuscin, being autofluorescent, nondegradable biological ‘garbage’, is
a hallmark of aging in postmitotic cells, such as cardiomyocytes and neu-
rons (Terman & Brunk, 2004). On high magnification examination using
electron microscopy, accumulation of lipofuscin was rarely observed in
the hearts of 12-week-old mice, whereas a large amount of intralysoso-
mal lipofuscin inclusions was detected in 104-week-old mice (Fig. 4A).
Prolonged culturing of NRCMs resembles the aging process in mice, as
lipofuscin was hardly detected at 4 days but had accumulated at
21 days, while the characteristic sarcomere structures were maintained
(Fig. 4A). Using optical imaging lipofuscin content per cardiomyocyte
increased >150-fold after 21 days compared to 4-day-old NRCMs
(Fig. 4B).
Beside lipofuscin accumulation, the aged myocardium is hallmarked by
increased matrix deposition. To study the production of collagen in aged
cardiomyocytes, we determined collagen type 1A1 and 3A1 levels.
RT-PCR analysis showed significant induction of the thin collagen type
3A1, but not the thicker type 1A1, in 21-day-old NRCMs (Fig. 4C), further
strengthening the aged phenotype of these cells. Taken together, pro-
longed culturing of NRCMs resembles two common characteristics of car-
diac aging in vivo and was therefore used to study age-related changes in
cardiomyocytes in vitro.
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Fig. 2 Opposite expression profiles in heart failure (HF)-resis-
tant versus HF-prone mice. CTGF, TSP-1, miR-18a, miR-19a,
and miR-19b levels in aged HF-resistant (12 weeks, n = 8;
52 weeks, n = 8; and 104 weeks, n = 9) and HF-prone mice
(12 weeks, n = 6; 52 weeks, n = 11; and 104 weeks, n = 9).
(A and B) Immunoblotting was performed on four mice per
age-group and revealed significant induction of CTGF and
TSP-1 protein expression in failing hearts of 104-week-old
HF-prone mice, whereas CTGF and TSP-1 levels were reduced
in old HF-resistant mice. Immunoblots show representative
protein bands of TSP-1, CTGF, and GAPDH. (C) RT-PCR analy-
sis showed increased expression of miR-18a, miR-19a, and
miR-19b in 104-week-old HF-resistant hearts, whereas age-
matched HF-prone mice had decreased expressions. miRNA
expression and CTGF and TSP-1 protein levels were normalized
for GAPDH expression and presented as mean ± SEM.
*P £ 0.05 vs 12 weeks of age; †P £ 0.05 vs 52 weeks of age;
$P = 0.05 vs 12 weeks of age.
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RT-PCR analysis showed that the expression levels of all members of
the miR-17–92 cluster were reduced in aged cardiomyocytes, except miR-
92a-1 (Fig. 4D and Supporting information Table S2). Importantly, miR-
18a, miR-19a, and miR-19b were among the most strongly repressed
miRNAs. Along with reduced expression of these miRNAs, CTGF and TSP-
1 transcript and protein levels were significantly induced in aged cardio-
myocytes (Fig. 4E, F). These findings confirm the expression profiles in
aged HF-prone mice and again suggest that miR-18a, miR-19a, and miR-
19b could transcriptionally repress CTGF and TSP-1 levels in cardiomyo-
cyte aging and HF at old age.
Cardiomyocyte CTGF and TSP-1 and collagen production are
regulated by miR-18 ⁄ 19
To investigate the cardiac localization of miR-18 and -19, we performed
in situ hybridization. MiR-18a and miR-19b are abundantly expressed in
the adult mouse heart and are predominantly localized in the perinuclear
area of cardiomyocytes (Fig. 5A–C). This was corroborated by the finding
that miR-18a and miR-19b expression was higher in cardiomyocytes com-
pared to cardiac fibroblasts (Fig. 5D). Importantly, the abundant expres-
sion of miR-18a and miR-19b in cardiomyocytes coincides with low levels
of CTGF and TSP-1, whereas in cardiac fibroblasts, relatively low levels of
miR-18a and miR-19b were associated with high CTGF and TSP-1 tran-
scription (Fig. 5E).
Next, we performed a series of functional studies to determine the role
of miR-18a and miR-19b in the regulation of CTGF and TSP-1 and colla-
gen production in cardiomyocytes and cardiac fibroblasts. Overexpression
of miR-18a and miR-19b, using miRNA mimics, resulted in significant
repression of CTGF and TSP-1 mRNA and protein expression in cardio-
myocytes (Fig. 5F and G; Supporting information Fig. S3A). Vice versa,
blunting of miR-18a and miR-19b using antagomirs was sufficient to
increase CTGF and TSP-1 transcript and protein levels in cardiomyocytes
(Fig. 5F, G; Supporting information Fig. S3A). Cardiac fibroblasts demon-
strated decreased CTGF and TSP-1 transcript levels upon introduction of
miR-18a and miR-19b; however, this did not result in reduced protein lev-
els (Fig. 5H, I). Along the same line, endogenous miRNA inhibition was
not sufficient to enhance CTGF and TSP-1 transcript and protein expres-
sion in cardiac fibroblasts (Fig. 5H, I; Supporting information Fig. S3B).
These results show that regulation of CTGF and TSP-1 by miR-18a and
miR-19b is uniquely restricted to the cardiomyocyte.
CTGF and TSP-1 are pro-fibrotic (Belmadani et al., 2007; Shi-Wen
et al., 2008), and therefore, we investigated whether their regulating
miRs-18a and miR-19b were also capable of affecting collagen produc-
tion. Indeed, overexpression of miR18a and miR-19b in cardiomyocytes
repressed collagen 1A1 and 3A1 mRNA levels, while inhibition of these
miRNAs using antagomirs significantly enhanced collagen transcription
(Fig. 6A). In contrast, collagen 1A1 and 3A1 transcription was not
affected by either miR-18a and miR-19b overexpression or inhibition in
neonatal rat cardiomyocytes and cardiac fibroblasts (NRCFs), indicating
that collagen expression in cardiac fibroblasts is unrelated to these miR-
NAs (Fig. 6B). Thus, in concordance with CTGF and TSP-1 regulation by
miR-18a and miR-19b in cardiomyocytes, these data strongly imply that
miR-18a and miR-19b contribute to the induction of collagen synthesis in
aged cardiomyocytes via the regulation of the pro-fibrotic CTGF and
TSP-1.
Discussion
With aging, cardiac function declines as the result of cardiomyocyte loss,
left ventricular hypertrophy, dilation and accumulation and remodeling
of the extracellular matrix (Lakatta & Sollott, 2002). It is well accepted
that genetic changes significantly contribute to the aging process in the
heart (Bodyak et al., 2002; Park & Prolla, 2005). Because of the highly
accessible mRNAmicroarray technique, most studies primarily focused on
the regulation of gene expression by transcriptional control. With the dis-
covery of miRNAs, now the emphasis is being expanded to the post-tran-
scriptional level of regulation that gives rise to these age-specific gene
profiles.
A study showing that the miRNA lin-4 and its target protein lin-14
determine life span in C. elegans has paved the way for exploring the role
of miRNAs in aging (Boehm & Slack, 2005). Now, increasing evidence on
miRNAs as mediators of age-associated pathologies, together with
reports of age-related changes in miRNA expression in aged organs and
senescent cells, points toward miRNA regulation as a common biological
mechanism that underlies aging and cellular senescence in different
organs and cell types (Mudhasani et al., 2008; Chen et al., 2010; Grillari
and Grillari-Voglauer, 2010). Nevertheless, so far no studies have
addressed the role of miRNAs in the old heart and aging of cardiomyo-
cytes.
In the present study, we showed extensive changes in the expression of
the miR-17–92 cluster in a model of age-related heart failure in mice. We
were able to extrapolate our findings to patients, which confirm the well-
recognized highly conserved nature of microRNAs and their target sites.
Initially, the miR-17–92 cluster was linked to cancer pathogenesis and
was thought to be pro-tumorgenic because of its regulation by c-Myc
(Dews et al., 2006). However, the cluster was later found to be tumor
suppressive in multiple forms of cancer (Zhang et al., 2006). Tumor sup-
pressor mechanisms can induce cellular senescence and contribute to the
aging process (Campisi, 2003), turning the miR-17–92 cluster into a
(A)
(B)
Fig. 3 CTGF and TSP-1 expression are elevated in human heart failure (HF). RT-
PCR analysis of miR-18a, miR-19a, miR-19b, CTGF, and TSP-1 transcript levels in
myocardial biopsies from idiopathic cardiomyopathy (ICM) patients at older age
with normal (n = 5) and severely impaired (n = 9) cardiac function. Transcript levels
were compared to the expression in young ICM subjects with a preserved cardiac
function (n = 5). (A) MiR-18a, miR-19a, and miR-19b expression was significantly
decreased in older ICM patients with HF. (B) CTGF and TSP-1 transcript levels were
significantly induced in older patients with a compromised cardiac function, when
compared to younger ICM subjects. All data were normalized for GAPDH
expression and presented as mean ± SEM. *P £ 0.05 vs young ICM patients.
$P = 0.06 in failing vs nonfailing hearts of older ICM patients.
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potential mediator of aging. Indeed, overexpression of miR-17 and miR-
20a inhibited senescence in primary human fibroblasts by blunting the
activation of p21WAF1, while inhibition of miR-17 caused senescence in
anaplastic thyroid cancer cells (Takakura et al., 2008; Hong et al., 2010).
Furthermore, miR-17–92 expression is consistently down-regulated in
multiple models of aging, i.e. after irradiation (Maes et al., 2008), p53
induction (Brosh et al., 2008), or stress-induced senescence (Li et al.,
2009), and in old human skin, bone-marrow-derived mesenchymal stem
cells, T cells (Hackl et al., 2010), and peripheral blood mononuclear cells
(Noren Hooten et al., 2010). These reports are in line with our data show-
ing repression of the miR17–92 cluster in old failing hearts. In addition,
we demonstrate that the miR-17–92 cluster is part of the senescence sig-
nature of the aged cardiomyocyte.
From the six members of the miR-17–92 cluster, miR-18a, miR-19a,
and miR-19b were among the most strongly repressed miRNAs in aged
cardiomyocytes and hearts of old failure-prone mice. Several studies have
linked these specific cluster members, and not the other cluster members,
to the matricellular proteins CTGF and TSP-1 (Dews et al., 2006; Suarez
et al., 2008; Ohgawara et al., 2009). Interestingly, CTGF upregulation in
age-induced cardiac disease correlates with TGF-b induction, cardiac
fibrosis, and left ventricular stiffening (Koitabashi et al., 2007; Wang
et al., 2010). The role of TSP-1 in cardiac aging was not reported so far,
but another member of the family of thrombospondins, TSP-2, was
recently shown to be up-regulated in aged hearts and to protect against
age-related cardiac dysfunction (Swinnen et al., 2009). Here, we showed
increased expression of CTGF and TSP-1 in age-related HF both in mice
and human.
Traditionally, it has been assumed that CTGF and TSP-1 are predomi-
nantly expressed by fibroblasts in the heart. However, several studies have
recognized that during cardiac remodeling, CTGF and TSP-1 are also
secreted by cardiomyocytes to regulate their surrounding ECM environ-
ment (Ohnishi et al., 1998; Chen et al., 2000; Frangogiannis et al.,
2005). Moreover, a role for miRNAs in regulating CTGF expression in car-
diomyocytes has been established by Duisters et al., (2009), who showed
that increased CTGF transcription during pathological LV hypertrophy in
(young) hearts is controlled by miR-30 and miR-133. Our in vitro results
support a role for miR-18a, miR-19a, and miR-19b in regulating CTGF
and TSP-1 expression in the aged cardiomyocyte. Here, miRNA mimics of
miR-18a and miR-19b blunted the expression of CTGF and TSP-1, and
vice versa, inhibition of these miRNAs enhanced CTGF and TSP-1 levels. In
cardiac fibroblasts, overexpression of miR-18a and miR-19b also
decreased CTGF and TSP-1 transcription; however, inhibition of these
miRNAs was not sufficient to increase CTGF and TSP-1. This may be
attributed to the fact that a fibroblast produces large amounts of CTGF
4 days 21 days
12 weeks, in vivo
4 days, in vitro 21 days, in vitro
104 weeks, in vivo 4 days, in vitro 21 days, in vitro
CTGF
GAPDH
TSP-1
(A) (B)
(C)
(E) (F)
(D)
Fig. 4 Aging-induced expression profiles in cardiomyocytes
in vitro. (A) Electron microscopic images of the left ventricle of
12- and 104-week-old mice, and 4- and 21-day-old neonatal
rat cardiomyocytes (NRCMs) showing perinuclear accumula-
tion of lipofuscin in cardiomyocytes of 104-week-old mice and
NRCMs after 21 days in culture. Scale bars represent 2 lm. (B)
Two-photon ⁄ confocal images and quantification of autofluo-
rescent lipofuscin granules (green) in cultured cardiomyocytes.
Nuclei are stained with Hoechst (blue). Scale bars represent
100 lm. (C) RT-PCR analysis showed significant induction of
collagen type 3A1 (COL3A1), but not collagen type 1A1
(COL1A1) in cultured NRCMs. (D) RT-PCR analysis revealed
decreased miR-18a, miR-19a, and miR-19b expression in aged
NRCMs after 21 days in culture. (E) CTGF and TSP-1 transcript
levels increased with NRCM aging in vitro. (F) Immunoblotting
confirmed the increase in CTGF and TSP-1 protein induction
during cardiomyocyte aging. All in vitro experiments were per-
formed with n = 3 per group, and protein and transcript levels
were normalized for GAPDH expression. Data were presented
as mean ± SEM. *P £ 0.05 vs 4-day-old NRCMs.
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and TSP-1 while it contains relatively low amounts of miR-18a and miR-
19b. These results imply that the age-related regulation of CTGF and TSP-
1 expression by miR-18a and miR-19b in the heart is uniquely restricted to
the cardiomyocyte to control its surrounding ECM.
In conclusion, our study is the first to show that miRNA expression of
the miR-17–92 cluster changes with cardiac aging and associates
decreased miR-18a, miR-19a, and miR-19b expression with age-related
remodeling in the heart. Our results suggest that up-regulation of these
19b
CTGF
TSP-1
Cardiomyocyte
TSP-1
Fibroblast
CTGF
CTGF
CTGF
GAPGH
GAPGH
Scrambled miR-18a miR-19a/b
TSP-1
TSP-1
scr 18a
Mimic
19bscr 18a
Mimic
19b
CTGF
GAPGH
TSP-1
scr 18a
Antagomir
CTGF
GAPGH
TSP-1
19bscr 18a
Antagomir
(A) (B) (C) (D)
(E)
(G)
(I)
(F)
(H)
Fig. 5 MiR-18a and miR-19b regulate CTGF and TSP-1 expression in cardiomyocytes. (A–C) In situ hybridization showed the abundant expression of miR-18a and miR-19b in
the myocardium of adult C57Bl6 mice, most of it expressed by cardiomyocytes. Black arrows indicate the cardiomyocyte nucleus and illustrate the perinuclear localization of
these miRNAs. (D and E) Comparison of the expression profiles in cultured neonatal rat cardiomyocytes (NRCMs) and neonatal rat cardiac fibroblasts (NRCFs) shows that
abundant expression of miR-18a and miR-19b in NRCMs is paralleled by low CTGF and TSP-1 transcript levels. (F and G) Immunoblotting revealed that manipulating miR-18a
and miR-19b function by overexpression of these miRNAs using mimics in NRCMs was sufficient to decrease CTGF and TSP-1 protein expression, while inhibition with
antagomirs enhanced CTGF and TSP-1 levels. (H and I) In contrast to NRCMs, immunoblotting in cultured NRCFs showed that CTGF and TSP-1 protein expression was not
suppressed by overexpression of miR-18a and miR-19b, nor did inhibition of these miRNAs result in increased CTGF and TSP-1 levels. Mimic and antagomir experiments were
performed with n = 4 per group, and data were normalized for GAPDH expression. Data were presented as mean ± SEM. *P £ 0.05 vs scrambled control oligonucleotides.
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miRNAs in the aged failure-protected heart blunts the expression of TSP-1
and CTGF to dampen the fibrotic remodeling process that contributes to
the functional decline with age. Although we do not show direct regula-
tion of CTGF and TSP-1 by these miRNAs, previous data have proven a
direct mechanism (Suarez et al., 2008; Ohgawara et al., 2009). This study
provides evidence for the involvement of miRNAs in regulating cardiac
aging and identifies them as potential new therapeutic targets for the
modulation of aging-induced cardiac remodeling.
Methods
An expandedMethods section is available in the Data S1.
Mice
Male C57Bl6 mice were obtained from Janvier (Le Genest Saint Isle,
France), and mice on a C57Bl6 · 129Sv genetic background were gener-
ated within the animal facility of the University of Maastricht. All animals
were housed under standard day–night rhythm and ad libitum conditions
until 12, 52, and 104 weeks of age. Cardiac function was assessed under
sedation (2% isoflurane), followed by removal of the hearts for further
histological and molecular analyses. For histology, hearts were fixed in
1% paraformaldehyde, embedded in paraffin, and stained with Sirius
red. For high magnification analysis, hearts were fixed in 2.5% glutaral-
dehyde. Electron microscopic images were made with a Philips CM100
(F.E.I., Eindhoven, The Netherlands).
This study was approved by the Institutional Animal Research Commit-
tee and conforms with the guidelines for the use of laboratory animals
formulated in the Dutch law on care and use of experimental animals.
Patients
Nineteen subjects diagnosed with ICM were included based on age
and cardiac function. Five old patients (60.5 years ± 0.8) with pre-
served cardiac function (ejection fraction between 40 and 55%) and
no signs of coronary artery disease (EF: 45.6% ± 9.2) and nine ICM
patients at older age (67.0 years ± 4.3) with a severely compromised
cardiac function (EF: 18.9% ± 3.0) were compared to a group of five
young patients (33.2 years ± 4.4) with preserved cardiac function (EF:
46.5% ± 4.4). This study occurred in line with the recommendations
of the institutional ethics committee of the University Hospital
Maastricht.
In vitro experiments
Neonatal rat cardiomyocytes and cardiac fibroblasts were isolated from
1- to 3-day-old Lewis rats as described previously (De Windt et al.,
1997).
For aging of cardiomyocytes in vitro, NRCMs were cultured for 4 and
21 days, and autofluorescent lipofuscin was excited using a laser at
488 nm, with confocal detection at 510–560 nm (Nikon Eclipse E600FN,
Tokyo, Japan). Hoechst-stained nuclei were excited with a two-photon
COL1A1
COL3A1
Cardiomyocyte
COL3A1
Fibroblast
COL1A1
(A)
(B)
Fig. 6 MiR-18a and miR-19b regulate collagen 1A1 and 3A1
expression in cardiomyocytes in vitro. RT-PCR analysis for the
induction collagen 1A1 (COL1A1) and collagen 3A1 (COL3A1)
in cultured neonatal rat cardiomyocytes and cardiac fibroblasts
after manipulation with miR-18a and miR-19b mimics and
antagomirs. (A) Overexpression of miR-18a and miR-19b in
cardiomyocytes significantly reduces collagen 1A1 and colla-
gen 3A1 transcript levels, while inhibition of these miRNAs
using antagomirs significantly induced transcription of both
collagen types. (B) Collagen 1A1 and 3A1 expression in cul-
tured cardiac fibroblasts seemed unrelated to miR-18a and
miR-19b, as no significant repression or induction was
observed in NRCFs after treatment with miR-18a and miR-19b
mimics or antagomirs, respectively. All experiments were per-
formed with n = 4 per group, and data were normalized for
GAPDH transcript levels. Data were presented as mean ± SEM.
*P £ 0.05 vs scrambled control oligonucleotides.
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Spectra-Physics Tsunami laser (Spectra-Physics, Irvine, CA, USA) centered
at 800 nm and visualized at 400–480 nm. The lipofuscin content per car-
diomyocyte was determined using Leica Qwin image processing and anal-
ysis software (Leica. Microsystems Cambridge Ltd, Cambridge, UK).
For the overexpression or inhibition of miR-18a and miR-19b, NRCMs
and NRCFs were transfected with 80 nm miRIDIAN hairpin inhibitor
(antagomiR) miR-18a (#IH-300487-06) or miR-19b (#IH-300489-05), or
with miRIDIAN mimic miR-18a (#C-300487-05), or miR-19b (#C-300489-
03) (Dharmacon, Colorado, CO, USA). Cells transfected with miRIDIAN
microRNA hairpin inhibitor negative control #1 (#IN-001005-01) and
miRIDIAN microRNA mimic negative control #2 (#CN-002000-01) served
as control groups.
RNA isolation and Real-time PCR
Total RNA was extracted from homogenized cells and heart tissues
using the mirVANA miRNA isolation kit (Ambion, Austin, TX, USA)
according to the manufacturer’s protocol. Gene transcript levels of
CTGF, TSP-1, collagen 1A1, and collagen 3A1 (primer sequences are
listed in Supporting information Table S3), or miRNA expression were
detected with the MyIQ Single Color Real-Time PCR detection System
(Bio-Rad, Hercules, CA, USA). MiR-17, miR18a, miR-19a, miR-19b, miR-
20, and miR-92a-1 expression was measured using miRNA-specific
miScript Primer Assays (Qiagen, Hilden, Germany). All expression levels
were presented relative to glyceraldehydes-3-phosphate dehydrogenase
(GAPDH).
Immunoblotting
Proteins were extracted from left ventricular heart tissue and in vitro from
NRCM and NRCFs. Protein lysates were separated by SDS–PAGE and
transferred to a polyvinylidene fluoride membrane (Immobilon-P,
0.45 lm pore size). The membranes were probed overnight at 4C with a
primary antibody to detect CTGF (#GTX26992; GeneTex Inc., Irvine, CA,
USA), TSP-1 (in-house rabbit anti-human TSP-1 was kindly provided by
MF Hoylaerts (Moura et al., 2008), University of Leuven, Belgium), and
glyceraldehyde-3-phosphate dehydrogenase (GAPDH) (#RDI-TRK5G4-
6C5; Fitzgerald Inc., Concord, MA, USA). Protein levels were determined
using Quantity One software (Bio-Rad, Hercules, CA, USA) and presented
relative to GAPDH protein expression.
In Situ Hybridization
Mouse left ventricular heart tissue was used for miRNA in situ hybridiza-
tion as described previously (Nuovo, 2010). Double DIG-labeled locked
nucleic acid (LNA) hybridization probes complementary to mouse mature
miR-18a (5DIGN ⁄CTATCTGCACTAGATGCACCTTA ⁄ 3DIG_N) (#38462-
15), miR-19b (5DIGN ⁄ TCAGTTTTGCATGGATTTGCACA ⁄ 3DIG_N) (#380
92-15), and a scrambled probe (5DIGN ⁄GTGTAACACGTCTATACGCC-
CA ⁄ 3DIG_N) (#99004-15) were purchased from Exiqon (Vedbaek,
Denmark).
Statistical analysis
All data are expressed as mean ± standard error of the mean (SEM). Dif-
ferences between groups were evaluated by Student’s t-test or one-way
ANOVA with Bonferroni post hoc test when appropriate. Differences in
interstitial and perivascular fibrosis were analyzed by two-way ANOVA and
Bonferroni post hoc test. Probability values <0.05 were considered statis-
tically significant.
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